Citation: | LIAO Qiu-lin, LAI Xu-wen, WU Xiao-li, HAN Li-fang, PENG Da-yun, ZHUANG Jie-na, LIAO Yue-yuan. Expression and significance of annexin A1 and S100A16 protein in human glioma[J]. Chinese Journal of General Practice, 2022, 20(10): 1672-1674. doi: 10.16766/j.cnki.issn.1674-4152.002675 |
[1] |
刘征, 徐国政. 胶质瘤相关循环生物标志物的研究进展[J]. 中国临床神经外科杂志, 2017, 22(3): 201-203. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGLC201703030.htm
LIU Z, XU G Z. Research progress of circulating biomarkers associated with glioma[J]. Chinese Journal of Clinical Neurosurgery, 2017(3): 201-203. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGLC201703030.htm
|
[2] |
LI Y, ALI S, CLARKE J, et al. Bevacizumab in recurrent glioma: Patterns of treatment failure and implications[J]. Brain Tumor Res Treat, 2017, 5(1): 1-9. doi: 10.14791/btrt.2017.5.1.1
|
[3] |
翁一鸣, 胡伟国, 宋启斌. 成人低级别胶质瘤术后治疗研究进展[J]. 肿瘤学杂志, 2017, 23(1): 60-64. doi: 10.3760/cma.j.issn.1673-422X.2017.01.016
WEN Y M, HU W G, SONG Q B. Progess of postoperative treatment for adult low grade glioma[J]. Journal of Chinese Oncology, 2017, 23(1): 60-64. doi: 10.3760/cma.j.issn.1673-422X.2017.01.016
|
[4] |
陈晓东, 廖秋林, 张伟, 等. 应用iTRAQ技术筛选DNT与低级别胶质瘤差异表达蛋白[J]. 中华全科医学, 2016, 14(7): 1077-1079, 1089. doi: 10.16766/j.cnki.issn.1674-4152.2016.07.005
CHEN X D, LIAO Q L, ZHANG W, et al. iTRAQ technology for differentially expressed proteins screening in dysembryoplastic neuroepithelial tumor and low grade glioma[J]. Chinese Journal of General Practice, 2016, 14(7): 1077-1079, 1089. doi: 10.16766/j.cnki.issn.1674-4152.2016.07.005
|
[5] |
王涛, 白培德, 谢顺强, 等. 膜联蛋白A1调控膀胱癌细胞增殖、凋亡及迁移的机制[J]. 中华泌尿外科杂志, 2019, 40(12): 932-936. doi: 10.3760/cma.j.issn.1000-6702.2019.12.012
WANG T, BAI P D, XIE S Q, et al. The mechanism of Annexin A1 regulating the proliferation, apoptosis and migration of bladder cancer cells[J]. Chinese Journal of Urology, 2019, 40(12): 932-936. doi: 10.3760/cma.j.issn.1000-6702.2019.12.012
|
[6] |
江若霞, 赵丽敏. 膜联蛋白A1基因的表达与胆囊癌临床病理的关系及调控信号转导与转录因子3信号通路对胆囊癌细胞增殖凋亡的影响[J]. 安徽医药, 2018, 22(6): 1082-1087. doi: 10.3969/j.issn.1009-6469.2018.06.020
JIANG R X, ZHAO L M. The relationship between the expression of ANXA1 gene and the clinical pathology of gallbladder carcinoma and the effect of STAT3 signaling pathway on the proliferation and apoptosis of gallbladder cancer cells[J]. Anhui Medical and Pharmaceutical Journal, 2018, 22(6): 1082-1087. doi: 10.3969/j.issn.1009-6469.2018.06.020
|
[7] |
TU Y, JOHNSTONE C N, STEWART A G. Annexin A1 influences in breast cancer: Controversies on contributions to tumour, host and immunoediting processes[J]. Pharmacol Res, 2017, 119: 278-288. doi: 10.1016/j.phrs.2017.02.011
|
[8] |
MORAES L A, KAR S, FOO S L, et al. Annexin-A1 enhances breast cancer growth and migration by promoting alternative macrophage polarization in the tumour microenvironment[J]. Sci Rep, 2017, 7: 17925. DOI: 10.1038/s41598-017-17622-5.
|
[9] |
陈晓, 魏立, 务森, 等. 膜联蛋白A1在食管癌组织的表达及其临床意义[J]. 中华实验外科杂志, 2017, 34(8): 1339-1341. doi: 10.3760/cma.j.issn.1001-9030.2017.08.024
CHEN X, WEI L, WU S, et al. Expression of annexin A1 protein in esophageal carcinoma and its clinical significance[J]. Chinese Journal of Experimental Surgery, 2017, 34(8): 1339-1341. doi: 10.3760/cma.j.issn.1001-9030.2017.08.024
|
[10] |
黄鑫, 陈博, 李自康, 等. 不同放化疗敏感性食管鳞状细胞癌中膜联蛋白A1的表达及预后因素分析[J]. 蚌埠医学院学报, 2019, 44(10): 1344-1348. https://www.cnki.com.cn/Article/CJFDTOTAL-BANG201910016.htm
HUANG X, CHEN B, LI Z K, et al. Expression of annexin A1 in ESCC with different chemoradiotherapy sensitivity and prognostic factors of ESCC[J]. Journal of Bengbu Medical College, 2019, 44(10): 1344-1348. https://www.cnki.com.cn/Article/CJFDTOTAL-BANG201910016.htm
|
[11] |
赖文芳, 黄鑫, 刘俊杰, 等. 片仔癀调控膜联蛋白A1/VEGF通路对人肝癌细胞系HepG2作用的影响[J]. 中国药理学通报, 2019, 35(11): 1534-1538. https://www.cnki.com.cn/Article/CJFDTOTAL-YAOL201911012.htm
LAI W F, HUAGN X, LIU J J, et al. Pien Tze Huang promotes HepG2 apoptosis via regulating ANXA1/VEGF signaling pathway[J]. Chinese Pharmacological Bulletin, 2019, 35(11): 1534-1538. https://www.cnki.com.cn/Article/CJFDTOTAL-YAOL201911012.htm
|
[12] |
FOO S L, YAP G, CUI J, et al. Annexin-A1-A blessing or a curse in cancer[J]. Trends Mol Med, 2019, 25: 315-327.
|
[13] |
蔡艳星, 刘烨, 杨洪芬. 膜联蛋白及其与胶质瘤关系的研究进展[J]. 解放军医药杂志, 2017, 29(8): 112-116. https://www.cnki.com.cn/Article/CJFDTOTAL-HBGF201708029.htm
CAI Y X, LIU Y, YANG H F. Advances in annexin and its relationship with glioma[J]. Medical & Pharmaceutical Journal of Chinese People ' s Liberation Army, 2017, 29(8): 112-116. https://www.cnki.com.cn/Article/CJFDTOTAL-HBGF201708029.htm
|
[14] |
李永明, 李海洋, 赵亚军, 等. 膜联蛋白A2调控人脑胶质瘤细胞侵袭迁移的研究[J]. 中华实验外科杂志, 2018, 35(3): 471-474.
LI Y M, LI H Y, ZHAO Y J, et al. Regulatory effect of annexin A2 on invasion and migration of human glioma cells[J]. Chinese Journal of Experimental Surgery, 2018, 35(3): 471-474.
|
[15] |
李璐, 奚玲, 薛一, 等. S100A16在前列腺癌中的表达及促进前列腺癌细胞侵袭的分子机制[J]. 东南大学学报(医学版), 2015, 34(1): 1-7. https://www.cnki.com.cn/Article/CJFDTOTAL-NJTD201501001.htm
LI L, XI L, XUE Y, et al. Expression of S100A16 in prostate cancer and the effects and mechanisms of S100A16 on human prostate cancer cells[J]. Journal of Southeast University(Medical Science Edition), 2015, 34(1): 1-7. https://www.cnki.com.cn/Article/CJFDTOTAL-NJTD201501001.htm
|
[16] |
MEDKOVA A, SROVNAL J, POTOMKOVA J, et al. Multifarious diagnostic possibilities of the S100 protein family: Predominantly in pediatrics and neonatology[J]. World J Pediatr, 2018, 14: 315-321.
|